Source BioScience opens new DNA sequencing facility in Tramore

The official opening of Source BioScience's DNA sequencing facility in Tramore, Ireland. (Photo: Business Wire)

DUBLIN--()--

Source BioScience plc

(‘Source BioScience’ or 'the Company')

Source BioScience has expanded its market leading DNA sequencing service in Ireland with the official opening of its new laboratory in Tramore, County Waterford.

The opening was conducted by John Perry TD, the Minister of State for Small Business, cutting the ceremonial ribbon alongside the Mayor of Tramore, Councillor Blaise Hannigan.

The new laboratory is key to the growth of Source BioScience’s DNA sequencing service in Ireland. The Tramore laboratory is strategically positioned between Cork and Dublin, providing an opportunity to expand the Overnight Shipment™ service to all areas of the country, enabling customers across Ireland to access their sequencing data within 24 hours.

The DNA sequencing laboratory complements Source BioScience’s existing controlled environment storage facility in Tramore, which provides IMB certified, GMP accredited stability storage at all ICH conditions, custom stability conditions and -80°C ultra-low temperature storage to customers in Ireland. Source BioScience designs and manufactures its own stability storage rooms and cabinets, ensuring the highest specification and service standards.

Nick Ash, CEO at Source BioScience, commented: “The investment demonstrates our long term commitment to Ireland. The country has a vibrant and growing life sciences and pharmabiotech industry, with some of the biggest names in the world located here. Tramore is a friendly community which supports local business and is a great place to work. We are delighted to be a part of this prosperous, growing region.”

About Source BioScience:

Source BioScience plc (LSE: SBS) is an international laboratory services and products business serving the healthcare and life science research markets. The Healthcare operations provide screening and reference laboratory diagnostic testing for cancer and other diseases in addition to complementary products for serology, diagnostics and sample storage. The LifeSciences division provides gene-based laboratory research support from conceptualisation to implementation, calling upon a wide range of innovative technology platforms and an online catalogue of biomolecular tools including cDNA clones and antibodies. The PharmaBiotech division provides support for drug discovery, from biomarker discovery and clinical trial services through to stability storage and sample archiving under environmentally controlled conditions. A superior quality management system, including GLP, GCP and CPA accreditations, make the services very attractive for applications in regulatory studies or in a clinical and diagnostic setting. Source BioScience has its headquarters in Nottingham, UK. For more information, see www.sourcebioscience.com.

Contacts

Source BioScience plc
Dr Nick Ash, CEO
Tel: +44 (0) 115 973 9010
Email: enquiries@sourcebioscience.com
www.sourcebioscience.com
or
For investor and media enquiries:
College Hill (PR Agency)
Melanie Toyne-Sewell/Donia Al Saffar
Tel: +44 (0)20 7457 2020
Email: sourcebioscience@collegehill.com

Contacts

Source BioScience plc
Dr Nick Ash, CEO
Tel: +44 (0) 115 973 9010
Email: enquiries@sourcebioscience.com
www.sourcebioscience.com
or
For investor and media enquiries:
College Hill (PR Agency)
Melanie Toyne-Sewell/Donia Al Saffar
Tel: +44 (0)20 7457 2020
Email: sourcebioscience@collegehill.com